Anemia is associated with adverse outcome after non-emergent percutaneous coronary intervention

被引：0
|
作者：
Raveendran, G [1 ]
Ting, HH [1 ]
Holmes, DR [1 ]
Lennon, RJ [1 ]
Best, PJM [1 ]
Singh, M [1 ]
Bell, MR [1 ]
Rihal, CS [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 7A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119H / 119H
页数：1
相关论文
共 50 条
  • [1] The impact of anemia on outcome after percutaneous coronary intervention
    Nikolsky, E
    Mehran, R
    Aymong, E
    Mintz, GS
    Dangas, G
    Lansky, AJ
    Negoita, M
    Pop, R
    Moses, JW
    Stone, GW
    Leon, MB
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 138L - 139L
  • [2] Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention
    Kandula, Praveen
    Shah, Ravish
    Singh, Nishith
    Markwell, Stephen J.
    Bhensdadia, Nishant
    Navaneethan, Sankar D.
    NEPHROLOGY, 2010, 15 (02) : 165 - 170
  • [3] Shedding blood: anemia and adverse events after percutaneous coronary intervention (PCI)
    Galougahi, Keyvan Karimi
    Karmpaliotis, Dimitri
    Kirtane, Ajay J.
    Ali, Ziad A.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (03) : 303 - 306
  • [4] Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergent percutaneous coronary intervention
    Chugh, SK
    Shewchuk, L
    Bonan, R
    Tardiff, JC
    Worthley, S
    Meredith, I
    DiMario, C
    Anderson, TJ
    EUROPEAN HEART JOURNAL, 2002, 23 : 68 - 68
  • [5] Is sex associated with adverse outcomes after percutaneous coronary intervention for CTO?
    Akodad, Mariama
    Spaziano, Marco
    Garcia-Alonso, Carlos J.
    Louvard, Yves
    Sanguineti, Francesca
    Garot, Philippe
    Hovasse, Thomas
    Unterseeh, Thierry
    Chevalier, Bernard
    Lefevre, Thierry
    Benamer, Hakim
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 288 : 29 - 33
  • [6] Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention
    Chanin, Jake M.
    Yang, David C.
    Haider, Muhammad A.
    Swaminathan, Rajesh V.
    Kim, Luke K.
    Charitakis, Konstantinos
    Tanoue, Michael
    Minutello, Robert M.
    Gade, Christopher L.
    Singh, Harsimran S.
    Bergman, Geoffrey
    Wong, S. Chiu
    Feldman, Dmitriy N.
    JOURNAL OF INVASIVE CARDIOLOGY, 2015, 27 (11): : 490 - 496
  • [7] NON-EMERGENT PERCUTANEOUS CORONARY INTERVENTION ON AN UNPROTECTED LEFT MAIN CORONARY ARTERY SUPPORTED WITH IMPELLA® HEART PUMP IN PATIENTS INELIGIBLE FOR SURGICAL REVASCULARIZATION
    Meraj, Perwaiz M.
    Hill, Jonathan
    Dixon, Simon
    Schreiber, Theodore
    Moses, Jeffrey
    Schaefer, Andreas
    O'Neill, William W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1281 - 1281
  • [8] Traditional clinical risk factors predict clopidogrel hypo-responsiveness in unselected patients undergoing non-emergent percutaneous coronary intervention
    Ratcovich, Hanna
    Holmvang, Lene
    Johansson, Par Inge
    Dridi, Nadia Parup
    PLATELETS, 2016, 27 (01) : 51 - 58
  • [9] The Influence of Anemia After Percutaneous Coronary Intervention on Clinical Outcomes
    Sattur, Sudhakar
    Harjai, Kishore J.
    Narula, Arvin
    Devarakonda, Srinivas
    Orshaw, Pamela
    Yaeger, Karl
    CIRCULATION, 2008, 118 (18) : S892 - S892
  • [10] Anemia is an independent predictor of mortality after percutaneous coronary intervention
    Lee, PC
    Kini, AS
    Ahsan, C
    Fisher, E
    Sharma, SK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (03) : 541 - 546
12345